These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11202057)

  • 1. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study.
    Andersson C; Floderus Y; Wikberg A; Lithner F
    Scand J Clin Lab Invest; 2000 Nov; 60(7):643-8. PubMed ID: 11202057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells.
    Mustajoki S; Laine M; Lahtela M; Mustajoki P; Peltonen L; Kauppinen R
    Mol Med; 2000 Aug; 6(8):670-9. PubMed ID: 11055586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.
    To-Figueras J; Badenas C; Carrera C; Muñoz C; Milá M; Lecha M; Herrero C
    J Inherit Metab Dis; 2006 Aug; 29(4):580-5. PubMed ID: 16817012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene.
    Floderus Y; Shoolingin-Jordan PM; Harper P
    Clin Genet; 2002 Oct; 62(4):288-97. PubMed ID: 12372055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic investigation of the porphobilinogen deaminase gene in Swedish acute intermittent porphyria families.
    Lundin G; Lee JS; Thunell S; Anvret M
    Hum Genet; 1997 Jul; 100(1):63-6. PubMed ID: 9225970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
    Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
    Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian "foreign Protestant" population with acute intermittent porphyria: a founder effect.
    Greene-Davis ST; Neumann PE; Mann OE; Moss MA; Schreiber WE; Welch JP; Langley GR; Sangalang VE; Dempsey GI; Nassar BA
    Clin Biochem; 1997 Dec; 30(8):607-12. PubMed ID: 9455613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria.
    Fraunberg MVUZ; Pischik E; Udd L; Kauppinen R
    Medicine (Baltimore); 2005 Jan; 84(1):35-47. PubMed ID: 15643298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria.
    Bustad HJ; Vorland M; Rønneseth E; Sandberg S; Martinez A; Toska K
    Biosci Rep; 2013 Aug; 33(4):. PubMed ID: 23815679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).
    Solis C; Lopez-Echaniz I; Sefarty-Graneda D; Astrin KH; Desnick RJ
    Mol Med; 1999 Oct; 5(10):664-71. PubMed ID: 10602775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute intermittent porphyria: rapid molecular diagnosis.
    Puy H; Aquaron R; Lamoril J; Robréau AM; Nordmann Y; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):37-45. PubMed ID: 9074787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W.
    Tjensvoll K; Bruland O; Floderus Y; Skadberg Ø; Sandberg S; Apold J
    Dis Markers; 2003-2004; 19(1):41-6. PubMed ID: 14757946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
    Ulbrichova D; Hrdinka M; Saudek V; Martasek P
    FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population.
    Hrdinka M; Puy H; Martasek P
    Physiol Res; 2006; 55 Suppl 2():S119-136. PubMed ID: 17298216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
    De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
    Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a prevalent nonsense mutation (W283X) and two novel mutations in the porphobilinogen deaminase gene of Swiss patients with acute intermittent porphyria.
    Schneider-Yin X; Bogard C; Rüfenacht UB; Puy H; Nordmann Y; Minder EI; Deybach J
    Hum Hered; 2000; 50(4):247-50. PubMed ID: 10782018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods.
    Andersson C; Thunell S; Floderus Y; Forsell C; Lundin G; Anvret M; Lannfelt L; Wetterberg L; Lithner F
    J Intern Med; 1995 Mar; 237(3):301-8. PubMed ID: 7891051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.